| Literature DB >> 26101797 |
Takatoshi Karasawa1, Peter S Steyger2.
Abstract
Cisplatin is one of the most widely-used drugs to treat cancers. However, its nephrotoxic and ototoxic side-effects remain major clinical limitations. Recent studies have improved our understanding of the molecular mechanisms of cisplatin-induced nephrotoxicity and ototoxicity. While cisplatin binding to DNA is the major cytotoxic mechanism in proliferating (cancer) cells, nephrotoxicity and ototoxicity appear to result from toxic levels of reactive oxygen species and protein dysregulation within various cellular compartments. In this review, we discuss molecular mechanisms of cisplatin-induced nephrotoxicity and ototoxicity. We also discuss potential clinical strategies to prevent nephrotoxicity and ototoxicity and their current limitations.Entities:
Keywords: Cisplatin; Intracellular mechanisms; Nephrotoxicity; Ototoxicity
Mesh:
Substances:
Year: 2015 PMID: 26101797 PMCID: PMC4516600 DOI: 10.1016/j.toxlet.2015.06.012
Source DB: PubMed Journal: Toxicol Lett ISSN: 0378-4274 Impact factor: 4.372